Cargando…

Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus

OBJECTIVE: To share our clinical experience with exenatide in obese North Indian subjects with type 2 diabetes. MATERIALS AND METHODS: We share our experience with use of exenatide in 74 patients treated at Indraprastha Apollo Hospital, a tertiary care centre in New Delhi, India Subjects included ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bawa, Tarunika, Dhingra, Vibha, Malhotra, Nidhi, Wasir, Jasjeet S., Mithal, Ambrish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659913/ https://www.ncbi.nlm.nih.gov/pubmed/23776858 http://dx.doi.org/10.4103/2230-8210.107804

Ejemplares similares

Once Weekly Dulaglutide Therapy in Type 2 Diabetic Subjects, Real-world Evidence from a Tertiary Care Diabetes Center in India
por: Wasir, Jasjeet S., et al.
Publicado: (2018)

Centile values for serum lipids and blood pressure for Asian Indian adolescents
por: Madhavan, Malini, et al.
Publicado: (2005)

Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

Usage of pioglitazone at Medanta, the Medicity
por: Mithal, Ambrish, et al.
Publicado: (2014)

Vitamin D and insulin resistance in postmenopausal Indian women
por: Agarwal, Niti, et al.
Publicado: (2014)

Effect of vitamin D supplementation on bone health parameters of healthy young Indian women
por: Malhotra, Nidhi, et al.
Publicado: (2009)

Pilot case-control investigation of risk factors for hip fractures in the urban Indian population
por: Jha, Ruchira M, et al.
Publicado: (2010)

Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
por: Sharma, Kamal, et al.
Publicado: (2021)

Effect of two different doses of oral cholecalciferol supplementation on serum 25-hydroxy-vitamin D levels in healthy Indian postmenopausal women: A randomized controlled trial
por: Agarwal, Niti, et al.
Publicado: (2013)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
por: Kaur, Parjeet, et al.
Publicado: (2016)

Exenatide Use in the Management of Type 2 Diabetes Mellitus
por: Kyriacou, Angelos, et al.
Publicado: (2010)

Indian Phenotype Characteristics Among Patients with Type 2 Diabetes Mellitus: Insights from a Non-interventional Nationwide Registry in India
por: Kalra, Sanjay, et al.
Publicado: (2022)

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013)

Dietary beliefs and eating patterns influence metabolic health in type 2 diabetes: A clinic-based study in urban North India
por: Colles, Susan L., et al.
Publicado: (2013)

Reference range of random urinary calcium creatinine ratio in North Indian children and adolescents
por: Marwaha, Raman Kumar, et al.
Publicado: (2019)

Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
por: KÖSEOĞLU, Derya, et al.
Publicado: (2021)

Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID)
por: Mithal, Ambrish, et al.
Publicado: (2014)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes Mellitus
por: Khan, Muhammad, et al.
Publicado: (2015)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Exenatide Effects on Cardiometabolic Risk and Weight in Adolescents with Morbid Obesity and Type 2 Diabetes Mellitus: Two Case Reports
por: Censani, Marisa, et al.
Publicado: (2015)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
por: Seewoodhary, Jason, et al.
Publicado: (2010)

Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2019)

Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus
por: Onishi, Yukiko, et al.
Publicado: (2012)

Gestational diabetes in India: Science and society
por: Mithal, Ambrish, et al.
Publicado: (2015)

Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
por: Sheu, Wayne Huey-Herng, et al.
Publicado: (2020)

Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India
por: Kaur, Parjeet, et al.
Publicado: (2014)

Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus
por: Pereira, Marie, et al.
Publicado: (2017)

Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus
por: Guclu, Metin, et al.
Publicado: (2017)

Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
por: Song, Jinfang, et al.
Publicado: (2022)

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
por: Liu, Jia, et al.
Publicado: (2017)

Once-Weekly Exenatide in Youth With Type 2 Diabetes
por: Tamborlane, William V., et al.
Publicado: (2022)

Evolution of Exenatide as a Diabetes Therapeutic
por: Bhavsar, Sunil, et al.
Publicado: (2013)

Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
por: Mohan, Viswanathan, et al.
Publicado: (2023)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
por: Watanabe, Yuusuke, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus
por: Capel, Margarita, et al.
Publicado: (2019)

Efficacy of Exenatide Administered Twice Daily in Body Mass Index Reduction in Patients with Type 2 Diabetes Mellitus
por: Zhang, Jie, et al.
Publicado: (2022)

Tolerability, effectiveness and predictive parameters for the therapeutic usefulness of exenatide in obese, Korean patients with type 2 diabetes
por: Song, Sun Ok, et al.
Publicado: (2013)

Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus
por: Zargar, Abdul H, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_evdai13gv3eevcuigd2s07ihh3